Biochips for better cancer therapy

February 25, 2014

Cancer is the second leading cause of disease-related death in the United States, and may overtake heart disease without aggressive new therapies. One promising area of cancer treatment is photodynamic therapy (PDT), which combines the agents of a photosensitive drug, light, and oxygen to attack cancerous tumors and lesions locally in the targeted region of the body by selective optical illumination.

Research being conducted by Prof. Euisik Yoon's group aims to dramatically accelerate progress in PDT. And it is being accomplished through a lab-on-a-chip measuring about the size of a quarter. At the heart of this biochip is a 5x5mm testing area that will test the interaction of the drug, light, and oxygen simultaneously, generating results in a fraction of the time of current testing practices.

"In cancer research doctors are always looking for better drugs," explained Dr. Xia Lou, a postdoctoral fellow in Prof. Yoon's group. "But there has always been a lack in the ability to efficiently test . Researchers are also hoping to get more reliable test results than is the norm. We are providing more precise drug test conditions to insure that the results we are getting will more closely match the actual results from ."

"PDT is a fairly complicated therapy because it requires light, oxygen and the drug, all three of which need to be carefully controlled," said Dr. Lou. "With chemotherapy, for example, you only control how much of the drug is used."

Biochips for better cancer therapy
The central testing area of this biochip is 5mm2. The inside structure is comprised of 3 layers, each testing a key element of the therapy: drug, oxygen, and light.

Photodynamic therapy uses a unique type of drug, called a photosensitizer, that generates high energy oxygen when activated by light, in this case an LED laser. The oxygen reaction destroys cells locally only in the immediate surrounding area, which in this case is the tumor, without damaging other healthy cells in the rest of the body. PDT may also prompt the patient's immune system to attack the tumor, whereas without treatment it will likely ignore it.

There are two primary challenges in PDT today. One is determining the best treatment plan for the patient, and the other is testing the efficacy of new and existing drugs. For example, the location of a tumor in the body will determine the amount of light needed to excite the drug, and will impact the amount of drug that is administered. Also, when testing new drugs, it is again important to know the amount of light needed to excite the reaction, and the strength of the reaction. This adds a high level of complexity compared to conventional drug testing that only tests one component, the itself.

Biochips for better cancer therapy
This 3D plot, generated from the biochip’s test results of actual cancer cells, tracks the simultaneous interactions of drug, oxygen, and light.

Current PDT testing methods might take more than 24 hours to acquire just 10 data points. "With our device," said Dr. Lou, "we can finish the testing in 1 hour and have 1,000 data points. The result is a very comprehensive understanding of how the 3 elements need to be manipulated for maximum effect in an individual patient."

Explore further: Light dynamics for cancer treatment

More information: "A high-throughput photodynamic therapy screening platform with on-chip control of multiple microenvironmental factors." Xia Lou,et al. Lab Chip, 2014,14, 892-901. DOI: 10.1039/C3LC51077H

Related Stories

Light dynamics for cancer treatment

May 3, 2012
Research is delving into refinement of a revolutionary cancer treatment, photodynamic therapy (PDT). Using light, reactive oxygen and photosensitisers linked to specially designed antibodies, scientists are on the threshold ...

COXEN model picks the best drug for ovarian cancer

February 18, 2014
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug ...

A fast and effective mechanism to combat an aggressive cancer

February 24, 2014
Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, ...

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.